Discharge Summary – Kidney Transplant
Patient: Anthony Delgado
MRN: [Redacted]
Date of Admission: 2025-06-11
Date of Discharge: 2025-06-16
Attending: Dr. Smith

Admission Diagnosis:
End-stage renal disease secondary to type 2 diabetes mellitus.

Hospital Course:
Mr. Delgado underwent deceased donor kidney transplant on 2025-06-11. Post-operatively, he demonstrated good urine output and rapid improvement in renal function (pre-op creatinine 7.8 → discharge creatinine 1.8). Tacrolimus initiated POD1 with target trough 8–10 ng/mL. Mycophenolate mofetil and prednisone taper per protocol. Prophylaxis started with TMP-SMX, valganciclovir, and fluconazole. No rejection, infection, or surgical complications.

Discharge Medications:
- Tacrolimus 2 mg BID
- Mycophenolate mofetil 1000 mg BID
- Prednisone taper (starting 30 mg daily)
- TMP-SMX SS daily
- Valganciclovir 450 mg daily
- Fluconazole 100 mg daily
- Insulin glargine and lispro as per endocrinology
- Amlodipine, atorvastatin, sevelamer continued

Follow-Up:
Clinic in 1 week with labs including tacrolimus trough, creatinine, CBC, CMP, DSA, and BK PCR.

Condition at Discharge:
Stable, ambulating independently, tolerating diet, incision clean.
